Introduction
============

As a group, sphingolipids are essential components of all eukaryotic cell membranes ([@B17]). In fungi, sphingolipids play an important role in a variety of biological processes like cell division ([@B21]), heat stress response ([@B37]), acid/alkaline tolerance ([@B54]; [@B73]), hyphae formation ([@B67]), domain formation ([@B57]) spore germination ([@B50]), endocytosis ([@B94]), signal transduction ([@B64]), apoptosis ([@B11]), pathogenesis and virulence ([@B54]; [@B73]). Endowed with unique chemical structure and synthesized by fungal specific enzymes, these sphingolipids are ideal drug targets ([@B62]). In this context, it is important to characterize sphingolipids in greater detail.

Characterization of various fungal sphingolipids requires the understanding of three key components (**Figure [1](#F1){ref-type="fig"}**). These are: the pathways of biosynthesis and degradation; structures of various sphingolipids being synthesized; understanding the ways for efficient extraction of sphingolipids from the cell and the precise methods for their analysis. A tremendous amount of literature in the field of fungal lipid metabolism allows us to categorically understand these components. In the sections below, we have described a literature based review of these key components of sphingolipid characterization, with an emphasis on mass spectrometry based structural and functional characterization of sphingolipids from pathogenic fungi.

![**Key components of sphingolipid characterization in fungi**.](fmicb-07-00501-g001){#F1}

In general, the structure of sphingolipids comprise a LCB backbone amide- linked to a fatty acid at C2 position and ester linked to a polar head group at C1 position ([@B16]). There is a large diversity in sphingoid bases of mammals ([@B42]), plants ([@B55]), and fungi ([@B16]). In fungal cells, *de novo* sphingolipid biosynthesis begins with condensation of *L*-serine and palmitoyl-CoA to form 3-ketodihydrosphingosine which is then reduced to dihydrosphingosine (d18:0 backbone; sphinganine; **Figure [2A](#F2){ref-type="fig"}**; [@B9]; [@B63]). This step leads to the formation of an 18 C containing LCB. Dihydrosphingosine is then amide linked to a fatty acid (usually α-hydroxylated, 18 or 16 C containing) by ceramide synthases to form dihydroceramide ([@B48]). Further, a Δ4-desaturation of the sphingoid backbone of dihydroceramide forms ceramide (d18:1 backbone; 4-sphingenine; [@B88]; [@B74]). Next, a Δ8-desaturation of the sphingoid backbone of Δ4-ceramide leads to formation of Δ4, Δ8-ceramide (d18:2 backbone; 4,8-sphingadienine; [@B84]; **Figure [2A](#F2){ref-type="fig"}**). A sphingolipid C9-methyl transferase catalyzes the addition of a methyl group at C9 position of the 4,8-sphingadienine base of Δ4, Δ8-ceramide to form 9-methyl-Δ4, Δ8-ceramide (d19:2 backbone; 9-methyl-4,8-sphingadienine; [@B87]; [@B83]; **Figure [2A](#F2){ref-type="fig"}**). Finally, a Gcs1 catalyzes the transfer of glucose moiety from the UDP-glucose onto the C1 hydroxyl group of the ceramide forming glucosylceramide ([@B73]). Although all the enzymatic steps are not well characterized, some have been studied in fungi like *Cryptococcus neoformans* ([@B73]; [@B83]), *Aspergillus nidulans* ([@B53]), *A. fumigatus* ([@B50]; [@B46]), *Fusarium graminearum* ([@B72]) and *Candida albicans* ([@B12]). Notably, glucosylceramide biosynthesis is absent in *Saccharomyces cerevisiae* and *C. glabrata* ([@B49]).

![**Sphingolipid biosynthesis in fungi. (A)** Scheme of fungal sphingolipid biosynthetic pathway. Enzymatic steps with reverse reaction shown in brackets are as follows: (1) Serine *C*-palmitoyl transferase; (2) 3-ketosphinganine reductase; (3) Dihydrosphingosine kinase \[Dihydrosphingosine-1P-phosphatase\]; (4) Long-chain base (LCB) phosphate lyase; (5) Dihydroceramide synthase; (6) Dihydroceramide C4 desaturase; (7) Ceramidase \[Ceramide synthase\]; (8) Sphingosine kinase \[Sphingosine-1P-phosphatase\]; (9) Ceramide C8 desaturase; (10) Sphingolipid C9 methyltransferase (Smt1); (11) Hexosyl ceramide synthase \[Hexosyl ceramidase\]; (12) Dihydrosphingosine C4-hydroxylase (13) Phytosphingosine kinase \[Phytosphingosine -1P-phosphatase\]; (14) Ceramide synthase \[Ceramidase\]; (15) Sphingolipid α-hydroxylase; (16) IPC synthase; (17) IPC mannosyl transferase; (18) Inositolphosphotransferase; (19) Inositol phosphosphingolipid phospholipase C. Major sphingoid backbone in fungi is composed of 18 C-atoms (shown in blue) and the fatty acyls attached to various sphingolipids comprise of 16--26 C-atoms (shown in red). Putative conversion steps of dihydroceramide to phytoceramide and to IPC are represented by dashed arrows. **(B)** Structure of fungal glucosylceramide. Long chain sphingoid backbone amide linked to a fatty acyl and linked by β-glycosidic bond to a polar head group (glucose) at C1 position. Unique features of fungal glucosylceramide are: Δ4 and Δ8 double bonds in the sphingoid backbone (shown in green), 9-methylation in the sphingoid backbone (shown in yellow), α-hydroxyl fatty acyl (shown in orange) and hydroxyl groups in the hexose moiety (shown in blue). **(C)** Structure of fungal IPC. The distinguished features of IPC's in fungi are: C3-hydroxylation of sphingoid backbone and α-hydroxyl fatty acyl (both shown in orange), phosphate linked inositol group (shown in grey). '*R*' represents 16--24 carbons in the fatty acyl chain.](fmicb-07-00501-g002){#F2}

In plants, 8-sphingenine (d18:1) and 4,8-sphingenine (d18:2) represent the major sphingoid bases, however, presence of the *cis-* and *trans-* isomeric forms result in nine different C18 sphingoid bases ([@B66]). This results in a complex mixture of glucosylceramide pool in plants ([@B35]). In mammals, the major sphingoid base is 4-sphingenine (d18:1) which is linked to 16 C fatty acid in the glucosylceramide structure ([@B49]). In contrast, the fungal glucosylceramide structure is rather unique. The sphingoid backbone is composed of 9-methyl-4,8-sphingadienine which is amide linked to α-hydroxylated C18:0 fatty acid (**Figure [2B](#F2){ref-type="fig"}**; [@B16]). Certain fungal species contain galactose instead of glucose in this cerebroside structure ([@B91]). The α-hydroxylated C16:0 and α-hydroxylated C18:1 are the two other major fatty acyls reported in the fungal cerebroside structure ([@B2]). The structures of different cerebrosides produced by fungi have been extensively reviewed by [@B3].

Fungi also produce phytoceramide ([@B34]). Dihydrosphingosine C4-hydroxylase catalyzes the addition of a hydroxyl group at C4 position of dihydrosphingosine backbone to produce phytosphingosine (t18:0 backbone; 4-hydroxysphinganine; [@B52]; **Figure [2A](#F2){ref-type="fig"}**). Ceramide synthases then transfer a non-hydroxylated fatty acid (18, 24 or 26 C containing) to amide group at C2 position to form phytoceramide ([@B12]). The fatty acyl moiety of the phytoceramides is α-hydroxylated by a sphingolipid α-hydroxylase to form αOH-phytoceramides ([@B27]). Both phytoceramides and αOH-phytoceramides are further converted to complex phosphosphingolipids such as IPC (transfer of phosphorylinositol group to phytoceramide), MIPC, (transfer of mannosyl group to IPC) and M(IP)~2~C, (transfer of a second phosphorylinositol group to MIPC; [@B23]). Although IPC derivatives are not reported in mammals, certain plants and kinetoplastid protozoa do produce IPC derivatives ([@B34]).

The t18:0 phytosphingosine backbone, C2 hygroxylated fatty acyls and phosphorylinositol containing polar head group are the unique feature of IPC derivatives (**Figure [2C](#F2){ref-type="fig"}**). IPC structures and pathway of synthesis have been characterized in several fungi like *S. cereviseae* ([@B20]; [@B90]), *C. neoformans* ([@B54]), *A. fumigatus* ([@B47]; [@B32]), *A. nidulans* ([@B4]), *Histoplasma capsulatum* ([@B25]), and *C. albicans* ([@B82]; [@B12]).

The re-cycling of fungal sphingolipids involves the production of sphingosine, sphingosine-1-phosphate, dihydrosphingosine-1-phosphate, and phytosphingosine-1-phosphate (**Figure [2A](#F2){ref-type="fig"}**). The ultimate degradation steps of sphingolipids are constituted by the catabolism of dihydrosphingosine-1-phosphate and sphingosine-1-phosphate into palmitaldehyde and phosphoryl ethanolamine ([@B43]; [@B80]) and the phytosphingosine-1-phosphate into 2-hydroxy-palmitaldehyde and phosphoryl ethanolamine ([@B45]), by the long-chain basse-1-phosphate lyases (**Figure [2A](#F2){ref-type="fig"}**).

The ability of fungal cells to produce sphingolipids with different sphingoid backbone structures adds to the complexity of the lipid mixtures ([@B25]). In addition to the backbone structure, the degree of unsaturation, fatty acyl chain lengths, methylation and hydroxylation modifications, all make it quite difficult to analyze these lipids using classical techniques like *in vivo* labeling ([@B13]), TLC ([@B89]) and GC ([@B10]). Therefore, advanced analytical methods for the analyses of these lipids are employed to characterize their structures.

In last two decades, several mass spectrometry techniques have been used to identify and characterize the total sphingolipid pool or the "sphingolipidome." A wide variety of mass spectrometry based methods are available in literature that allows accurate analyses of these complex sphingolipid mixtures ([@B61], [@B60]; [@B31]; [@B92]; [@B44]). Below we describe methods of extraction, chromatographic separation and the mass spectrometry based strategies to analyze sphingolipids.

Lipid Extraction
================

Extraction of lipids is the most crucial step for lipid analysis by both classical and high throughput techniques. Currently several modified adaptations of Folch method ([@B22]) and Bligh and Dyer method ([@B6]) are being employed to extract lipids from fungal cells ([@B70]; [@B78]; [@B20]; [@B31]). In our laboratory and others, we use the method described by [@B56] for lipid extraction. This method has shown a good extraction efficiency and reproducibility for lipid analyses. The scheme of lipid extraction from fungal cells is shown in **Figure [3](#F3){ref-type="fig"}**. Fungal cells are extracted in ethanol: dH~2~O:diethylether:pyridine:NH4OH (15:15:5:1:0.018; v/v) at 60°C for 1 h as described previously ([@B30]). Lipid extract is then subjected to a solution of methanol:chloroform (2:1; v/v) followed by addition of 1/3rd volume chloroform and 1/3rd volume dH~2~O and the lower organic phase reserved ([@B6]). Organic phase is dried in SpeedVac, flushed with N~2~ and stored in -20°C. At this stage, these lipid extracts can be used for the estimation of inorganic phosphate (Pi) content, dry lipid weight or for the isolation and purification specific lipid classes ([@B60]; [@B71]). Both Pi content and dry lipid weight have been used to normalize the lipid amounts. Several groups have employed SPE techniques to further purify specific sphingolipid groups ([@B7]; [@B2]). Extensive lipid purification by SPE is cumbersome and time consuming, and is usually not required for routine lipid analysis; however, is preferred for a thorough structural characterization of complex glycosphingolipids ([@B2], [@B3]).

![**Procedure of sphingolipid extraction.** Prior to extraction, fungal cell extracts or lyophilized media are spiked with suitable internal standards. First extraction is performed using Mandala extraction buffer (ethanol: dH~2~O: diethyl ether: pyridine: 4.2N NH~4~OH; 15: 15: 5: 1: 0.018; v/v). Subsequently, a second Bligh and Dyer extraction is performed using methanol and chloroform. Samples at this stage can be used to determine the Pi content, lipid dry weight or to purify specific sphingolipid components using solid phase extraction. Finally, samples are base hydrolyzed using mild alkaline base hydrolysis (0.6 M KOH in methanol) to remove the glycerol backbone containing lipid contaminants. For certain fungal masses it is required to first crush the sample using glass beads in the lipid extraction buffer itself or to make the sample into powder using pestle and mortar in liquid N~2~ prior to extraction.](fmicb-07-00501-g003){#F3}

Glycerolipids are the major lipid contaminants that are co-extracted with sphingolipids ([@B6]). A mild alkaline methanolysis ([@B15]), usually for 60 min at room temperature is sufficient to hydrolyze the ester linkages of fatty acyls of glycerolipids. This allows a clean extraction of alkaline-stable components, which are highly enriched in sphingolipids.

For accurate quantification of lipids by mass spectrometry, internal standards must be added prior to lipid extraction ([@B71]). Although, absolute quantification of each lipid species by mass spectrometry requires the use of isotope-labeled standard for that species ([@B18]); however, presently this is not possible due to high synthesis costs and the large number of lipids being analyzed. Addition of one internal standard per lipid class being analyzed is widely accepted (LIPID MAPS Consortium). This is primarily because the ionization of lipid species is largely dependent upon the specific head group rather than the attached fatty acyls ([@B44]). The C17-sphingoid backbone lipids (Avanti Polar Lipids Inc., Alabaster, AL, USA; Matreya Inc., Pleasant Gap, PA, USA) are routinely used as internal standards as these closely resemble C18 lipids in physicochemical properties and ionization efficiencies ([@B71]). Quantification of sphingolipid species with different chain lengths can be achieved using the calibration curves of closest chain length standards ([@B71]).

Methods of Lipid Analysis
=========================

*In Vivo* Labeling, Thin-layer Chromatography and Gas Chromatography Mass Spectrometry
--------------------------------------------------------------------------------------

For several decades, *in vivo* labeling has been used to characterize the sphingolipid metabolic pathways in fungi ([@B13]). The technique involves the uptake of a radiolabeled precursor by cells. The radiolabeled precursor then gets incorporated into the complex lipid structures. Heavy labeled \[^14^C\]-palmitate and \[^14^C\]-serine are the most commonly used labeled precursors to follow sphingolipid synthesis ([@B13]). However, these labels get incorporated into other untargeted lipids and give high background signals. \[^3^H\]-dihydrosphingosine provides a more sphingolipid specific labeling ([@B41]). \[^3^H\]-inositol has been used to focus on IPC derivatives ([@B27]) and \[^3^H\]- or \[^14^C\]- glucose or galactose have been used to focus on glycosphingolipids ([@B77]). Unfortunately, the very long half-life of these radiolabeled precursors presents a serious risk to health if exposed and is a challenge during disposal ([@B18]).

Lipid extracts from labeled or unlabeled cells can be resolved using the TLC technique (**Figure [4A](#F4){ref-type="fig"}**). It is a simple, cost effective, fast and sensitive method to qualitatively characterize lipids. Identification of broad lipid classes by TLC is simple and achieved by comparing their mobility to the standard ([@B89]). The most commonly used solvent systems to resolve sphingolipids on a TLC include: chloroform:methanol:dH~2~O (65:25:4; v/v), chloroform:methanol:4.2N NH~4~OH (9:7:2 and 40:10:1; v/v) and chloroform:methanol:acetic acid (90:2:8; v/v [@B56]; [@B7]; [@B2]). Unlabeled sphingolipids are visualized using iodine ([@B68]) or orcinol/resorcinol staining ([@B86]) and the labeled sphingolipid are visualized by autoradiography on an X-ray film ([@B45]).

![**Strategy for mass spectrometry based identification of sphinglipids. (A)** Alternate strategies to confirm the sphingolipid structure. Qualitative analysis of sphingolipids can be performed using commercially available standards by High performance thin-layer chromatography (HP-TLC) or TLC. Sphingolipid components like sphingoid backbone, sugar and fatty can be analyzed using Gas chromatography mass spectrometry (GCMS). For sphingoid base and sugar analysis, samples are prepared using following steps: acid methanolysis (1 N HCl in methanol), *N*-acetylation (pyridine and acetic anhydride) and per-*O*-trimethylsilylation \[TriSil reagent; 1-(Trimethylsilyl)imidazole -- Pyridine mixture\]. Sphingoid bases and sugars are analyzed as *N*-acetyl-per-*O*-trimethylsilyl derivatives and monosaccharide methyl glycosides, respectively. For fatty acyl analysis, samples are prepared using acid methanolysis, re-extraction in *n*-hexane and per-*O*-trimethylsilylated (TriSil) to form fatty acid methyl esters (FAMEs). **(B)** A scheme of HPLC-ESI-MS/MS. Lipids are resolved by HPLC and thereafter analyzed by tandem mass spectrometry (MS/MS). 'Q1' and 'Q3' quadruples are mass analyzers and the quadrupole '*q*' operates in radio frequency leading to collision-induced dissociation (CID). Electrospray ionization (ESI) or Atmospheric pressure chemical ionization (APCI, not shown) is used as ionization methods. **(C)** Scheme for Q1-MS or full scan. The molecular ions or *m/z* ratio are recorded in Q1. **(D)** Scheme for product ion scanning. Only a select ion with specific *m/z* is recorded in Q1 and undergoes CID. Resultant ions are recorded in Q3. '*M*' represents the molecular ion; '*X*' represents a fragment loss. **(E)** Scheme for parent ion scanning. A full scan of ions recorded in Q1 and following CID, only a select fragment ion is recorded in Q3. **(F)** Scheme for single-reaction monitoring (SRM). A preselected ion is recorded in Q1, a select parent ion undergoes CID and a select fragment ion is recorded in Q3. **(G)** Scheme for multiple-reaction monitoring (MRM). Multiple SRM's can be set up simultaneously depending upon the scanning efficiency of the instrument. **(H)** Scheme for neutral loss (NL) scanning. Ions are recorded in both Q1 and Q3 with a set mass difference between the two.](fmicb-07-00501-g004){#F4}

Structural composition of the purified sphingolipids can be determined using GC-EI-MS ([@B10]). Only the volatile components that can be carried by the carrier gas (He) can be analyzed by GCMS. Most sphingolipid structures are non-volatile. For this reason, sphingolipids are hydrolyzed to release the fatty acid, sugar, and LCB components, which are then derivatized into methyl esters or TMS derivatives and analyzed by GC-EI-MS (**Figure [4A](#F4){ref-type="fig"}**; [@B14]; [@B58]; [@B39]; [@B59]). GC-EI-MS is not a preferred technique to analyze sphingolipids because fragmentation obtained in EI-MS is not very consistent as high energy electrons are used for fragmentation, strong ionization may completely destroy the molecular ion and extensive derivatization may generate complicated spectral patterns with poor resolution ([@B10]).

High-performance Liquid Chromatography (HPLC)
---------------------------------------------

Various sphingolipid classes can readily be separated by HPLC on both the normal phase C18 and reverse phase C8 columns. Normal phase HPLC utilizes the head group properties to obtain separation (for example, ceramides and hexosylceramides; [@B61]). However, the reverse phase HPLC using C8 column is capable of resolving sphingolipid classes based on their hydrophobicity of carbon backbone and degree of unsaturation (for example, sphingosine and dihydrosphingosine; [@B71]). During most of the routine sphingolipid analysis the reverse phase HPLC when coupled with mass spectrometry is a powerful tool for simultaneous separation and detection of sphingolipid species. The main goal of HPLC is to chromatographically separate the sphingolipid species that cannot be resolved based on *m/z* (mass-to-charge) by the mass spectrometers, like isomeric and isobaric species, and to improve the sensitivity of detection. Several different buffer systems have been described as mobile phases ([@B61]). The binary buffer system most frequently used as the mobile phase in sphingolipid analysis is: 2 mM ammonium formate + 0.2% formic acid in H~2~O (Buffer 1) and 1 mM ammonium formate + 0.2% formic acid in methanol (Buffer 2). A gradient elution of analytes using buffers 1 and 2 allows complete separation of sphingolipid species. Additional separation on HPLC may be achieved by lowering the flow rate of the mobile phase and changing the gradient conditions ([@B71]).

Fungal lipid extracts may contain a mixture of glucosyl- and galactosyl- ceramides ([@B2]). Due to a remarkable similarity in their backbone structures these lipid species are difficult to separate. These lipid species can be chromatographically separated using HILIC on silica based columns using isocratic elution ([@B93]). The elution buffer contains acetonitrile:methanol:acetic acid (97:2:1; v/v) + 5 mM ammonium acetate ([@B61]).

Advanced Mass Spectrometry
--------------------------

A wide variety of mass spectrometry platforms are now available that can be used to analyze the molecular composition of complex lipid mixtures ([@B44]). Mass spectrometry is a structure-based analysis of biological molecules ([@B92]), and has been extensively used to characterize various sphingolipid species ([@B85]; [@B8]; [@B51]; [@B65]).

Several different ionization methods have been used in sphingolipid analysis, for example, the ESI ([@B29]), MALDI ([@B40]), and FAB ([@B1]). These ionization techniques are coupled with mass analyzers like MS/MS ([@B81]), MS^n^ ([@B36]), TOF ([@B38]), FT-ICR ([@B26]), and QqTOF MS ([@B19]). The advantages and disadvantages of these techniques have been described in detail previously ([@B44]).

For sphingolipidomic purposes, ESI-MS/MS approach is most extensively employed. Coupled with reverse phase HPLC, ESI-MS/MS provides a simple, sensitive, and structure specific quantification of sphingolipids. Although the setup of other lipidomic platforms may be different but the basic concepts of mass spectrometry remain the same.

The primary requisition of any analytes to be analyzed by mass spectrometry depends on the fact that whether they can be readily ionized in gaseous phase without in source fragmentation ([@B29]). ESI is a soft-ionization technique that allows the formation of intact positively or negatively charged ions that are then transmitted to the mass analyzers. In a typical ESI source, analytes in solvents are infused into the ion source via a narrow capillary needle. A high voltage, positive or negative depending upon the lipids being targeted, is applied between the tip of the needle and the inlet of mass analyzer. This results in the formation of a charged droplet which gets desolvated under high voltage, vacuum and a drying N~2~ gas, leading to the production of charged molecular ions in gaseous phase ([@B8]). Sphingolipids are readily ionized in ESI source to form \[M + H\]^+^ molecular ions for long chain sphingoid bases, ceramides, and glycosphingolipids, or to from \[M-H\]^-^ molecular ions for IPC derivatives ([@B81]).

A scheme for HPLC-ESI-MS/MS is summarized in **Figure [4B](#F4){ref-type="fig"}**. Different scanning approaches have developed around this triple quadrupole set up ([@B29]; [@B61]; [@B5]; [@B24]; [@B8]; [@B71]), and these are:

1.  *Full scan* (**Figure [4C](#F4){ref-type="fig"}**): In a full scan, the *m/z* of molecular ions generated in ESI are recorded in the first quadrupole or the first mass analyzer. Full scan approach is widely used in non-targeted lipidomics. However, no structural information can be deduced from these scanning.

2.  *Product ion scanning* (**Figure [4D](#F4){ref-type="fig"}**): In this mode, the first mass analyzer allows a molecular ion of specific *m/z* to pass to the collision cell. Based on the applied CE the molecular ion is fragmented into product ions using an inert collision gas (N~2~ or Ar) via RF; this process is referred as CID. The *m/z* of these fragments is recorded in the third quadrupole or the second mass analyzer. For sphingolipids, the product ion analysis provides valuable structural information about the sphingoid backbone, polar head groups and the fatty acyl attached. For example, in positive ion mode, at high CE, glucosylceramide is fragmented into a characteristic ion representing the loss of double dehydration product of sphingoid backbone (**Figure [4D](#F4){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**). Similar ions characteristic to specific sphingolipid structures are identified and further used for lipid detection. Optimization of CE is important to obtain correct fragmentation of the molecular ions into desired daughter ions. CE required for achieving CID of different sphingolipid molecular species may vary depending upon hydroxylations, unsaturations, and carbon chain length.

###### 

Sphingoid backbones and polar head groups of fungal sphingolipids.

  ------------------------------
  ![](fmicb-07-00501-t001.jpg)
  ------------------------------

1.  *Parent- or precursor-ion scanning (PREIS;* **Figure [4E](#F4){ref-type="fig"}**): Here, the mass analyzer records molecular ions based on their *m/z*, these ions undergo CID, and only a select daughter ion is passed into the third quadrupole. This mode is very useful in the analysis of sphingolipid species which posses a common backbone or headgroup fragment.

2.  *Single-reaction monitoring (SRM;* **Figure [4F](#F4){ref-type="fig"}**): Only a select parent ion is recorded in the first quadrupole and undergoes CID and *m/z* of a select daughter ion is recorded in the third quadrupole. SRM's are highly selective and very sensitive methods.

3.  *Multiple-reaction monitoring (MRM;* **Figure [4G](#F4){ref-type="fig"}**): Several SRM reactions can be simultaneously recorded by the mass spectrometer, however, this largely depends upon the scanning speed of the instrument. MRM scanning represents a targeted lipidomics approach and is quite successfully used for the analysis of sphingolipids.

4.  *Neutral loss (NL) scanning* (**Figure [4H](#F4){ref-type="fig"}**): Both first and third quadrupole records the *m/z*, with a constant mass offset between them. For example, a NL of 18 amu is set, which represents a loss of water molecule from the molecular ion and is characteristic of sphingolipid structures ([@B71]).

A large amount of literature containing the fragmentation pattern of different sphingolipid classes is now available. Most of these fragmentation data (product ions) were acquired using direct infusion ESI-MS/MS approaches. This, however, requires extensive oﬄine purification of sphingolipid of interest, usually using SPE ([@B2]). Fortunately a large amount of literature containing the fragmentation patterns of various fungal sphingolipids is available and sphingolipid class-specific fragment and precursor ions are known for most classes ([@B24]). In targeted lipidomics, the unique precursor and parent ions are selected for each sphingolipid species and a MRM based method is employed for analyses ([@B5]).

Analysis of Fungal Sphingolipids
================================

By using a precursor *m/z* and product *m/z* ion pairs of molecular species of interest, an accurate detection and quantification can be done. Although the complete sphingolipidome for most fungi is yet to be determined, many sphingolipid specific backbones and polar head groups have been characterized (summarized in **Table [1](#T1){ref-type="table"}**). Targeted methods using PREIS and MRM scanning methods have been developed using these fragments to trace the sphingolipid metabolism of many fungi ([@B5]; [@B24]; [@B20]; [@B85]; [@B8]; [@B51]; [@B65]).

For example, dihydrosphingosine (d18:0) and sphingosine (d18:1) can be identified using precursor ions of *m/z* 302 and 300, and product ions of *m/z* 266 and 264, respectively, in the positive ion mode. Ions of *m/z* 266 and 264 are a result of loss of two water molecules from the sphingoid backbone. Loss of one water molecule from the backbone results ions of *m/z* 284 and 282. However, the lipid extracts may contain a mixture of d18:1 backbone with a difference in the position of double bonds, like 4-Sphingenine (major species) and 8-Sphingenine. In this situation, a prior chromatographic separation of these species is important and can be achieved by optimizing the mobile phase. The d18:0 backbone fragment ion *m/z* 266 is used to analyze dihydroceramide species while the d18:1 backbone fragment ion *m/z* 264 is used to analyze ceramide species. The phytosphingosine backbone (t18:0) is abundant in fungal lipid extract, and is constituent of phytoceramides and IPC derivatives. A precursor ion *m/z* 282 is characteristic to t18:0 backbone and results from the loss of two water molecules. Similarly, a rather less abundant t20:0 (4R-Hydroxy-eicosasphinganine) backbone is also detectable in phytoceramide and IPC structures using the positive ion precursor *m/z* 310. The presence of phosphorylinositol group/s in IPC, MIPC, and M(IP)~2~C structure often results in poor ionization efficiencies in positive ion mode. However, these lipids are readily ionized using negative ion mode and can be detected as \[M--H\]^-^. The precursor ion with *m/z* 241 which represents a dehydration product of the ion *m/z* 259 (the phosphorylinositol group) and can be used to analyze IPC and M(IP)~2~C species. Similarly, the precursor ion *m/z* 421 is used to analyze MIPC species (**Table [1](#T1){ref-type="table"}**; [@B24]; [@B20]; [@B85]).

The mass spectrometric analyses of purified lipids, especially cerebrosides, from different fungal sources have revealed several other complex backbone structures ([@B3]). Among these 9-methyl-4,8-sphingadiene (d19:2) is predominant in most fungal species like *Cryptococcus, Aspergillus, Candida*, and several others ([@B16]). The d19:2 backbone has a characteristic fragment of *m/z* 276 that results from the loss of two water molecules. The corresponding hexosylceramide can be identified in positive ion mode using \[M + H\]^+^ as the parent ion. The \[M + H\]^+^ ions 756, 754, and 728 represent three most abundant hexosylceramides in fungi. The 2-hydroxy fatty acyl group in these structures is C~18:0~, C~18:1~, and C~16:0~. It is important to mention here that often the ions for these lipid species present themselves as Na^+^ or K^+^ adducts in positive ion or Cl^-^ adduct in the negative ion mode. Analysis of such samples requires optimization of the CE and accounting for the altered mass during the analysis. Interestingly, the differential fragmentation pattern of Cl^-^ adduct of hexosylceramide in negative ESI-MS/MS mode can be used to identify the nature of the hexose moiety (glucose or galactose). This achievable by monitoring the peak intensity ratios of two characteristic product ions: *m/z* 179 and 89. The ion intensity patterns of 179 \< 89 and 179 \> 89 represent galactose and glucose moiety in the hexosylceramide structure, respectively ([@B28]).

The 4,8-Sphingadiene (d18:2) backbone containing sphingolipid species are also common in fungi. These can be analyzed using a precursor ion *m/z* 262. Although, the *cis-* or *trans-* isomers of d19:2 and d18:2 are not reported in fungi, however, an HPLC-ESI-MS/MS based method for analysis of these was recently described using plant lipid extracts ([@B35]). Several unique sphingoid backbones in cerebroside structures have also been identified in fungi like 4-Hydroxy-9-methyl-4,8-sphingadiene (d19:2~OH~) in *Scedosporium apiospermum* and *Pseudallescheria boydii* ([@B69]; [@B75]), 4-Amino-9-methyl-8-nonadecene-1,3,4-triol (d20:1) and 4-Amino-9-methyl-4,8-nonadecadiene-1,3-diol (d20:2) in *Cladosporium resinae* ([@B3]).

Our ability to accurately quantify different sphingolipid structures has been efficiently used to establish the sphingolipid biosynthetic pathways in fungi. Considering that differences in the biosynthesis of various sphingolipid structures can have drastic physiological affect on fungi, it becomes necessary to understand the enzymatic steps involved therein. This has been successfully achieved for several fungal species by comparing the sphingolipid profiles of the wild type and various sphingolipid pathway mutants ([@B47]; [@B32]; [@B54]; [@B4]; [@B20]; [@B12]; [@B25]; [@B90]). In a similar scenario, our lab worked out the glucosylceramide biosynthetic pathway of *C. neofomans* (shown in **Figure [5A](#F5){ref-type="fig"}**; [@B73]; [@B83]). Lipid analysis of wild type *C. neofomans* strain (CnWT) showed that 1′-β-[D]{.smallcaps}-glucosyl-2′-*N*-hydroxyoctadecanoyl-9-methyl-4,8-sphingadiene (or Δ4--Δ8,9Me-GlcCer, detected using the SRM transition of *m/z* 756 to 276; loss of double dehydrated sphingoid base) was the most abundant cerebroside structure (**Figure [5B](#F5){ref-type="fig"}**, panel 1). The corresponding ceramide species 2′-*N*-hydroxyoctadecanoyl-9-methyl-4,8-sphingadiene (or Δ4--Δ8,9Me-Cer, detected using the SRM transition of *m/z* 594 to 576; water loss) was also detectable. The deletion of *SMT1* (CnΔ*smt1*) abolishes the Smt1 activity, leading to an accumulation of un-methylated ceramide and glucosylceramide structures (**Figure [5B](#F5){ref-type="fig"}**, panel 2). These are 2′-*N*-hydroxyoctadecanoyl-4,8-sphingadiene (or Δ4--Δ8-Cer, detected using the SRM transition of *m/z* 580 to 562; water loss) and 1′-β-[D]{.smallcaps}-glucosyl-2′-*N*-hydroxyoctadecanoyl-4,8-sphingadiene (or Δ4--Δ8-GlcCer, detected using the SRM transition of *m/z* 742 to 262; loss of double dehydrated sphingoid base), respectively. The Δ4--Δ8,9Me-Cer and Δ4--Δ8,9Me-GlcCer structures are absent in CnΔ*smt1* mutant. These data confirmed that methylation of ceramide by Smt1 is a pre-requisite to the formation of methylated glucosylceramide. A deletion of glucosylceramide synthase *GCS1* (CnΔ*smt1*) leads to an accumulation of Δ4--Δ8,9Me-Cer; however, all glucosylceramide structures are completely absent, suggesting that Gcs1 is the key Gcs1 in *C. neofomans*. A similar approach can also be used to study the function of Sld8, (uncharacterized in *C. neoformans*), where 2′-*N*-hydroxyoctadecanoyl-4-sphingenine (Δ4-Cer) can be detected using the SRM transition of *m/z* 582 to 564 (water loss) and 1′-β-[D]{.smallcaps}-glucosyl-2′-*N*-hydroxyoctadecanoyl-4-sphingenine (Δ4- GlcCer) can be detected using the SRM transition of *m/z* 744 to 264 (loss of double dehydrated sphingoid base). Thus, combined with genetic approaches, mass spectrometry becomes extremely useful in understanding the lipid metabolism.

![**Analysis of ceramides and glucosylceramides of *Cryptococcus neoformans* using MRM approach. (A)** Partial pathway and structures of glucosylceramide biosynthetic pathway of *C. neoformans*. Δ4-Cer \[I\] is converted to Δ4, Δ8-Cer \[II\] by Δ8-desaturase (Sld8). Δ4--8-Cer is then methylated at C9 position of sphingoid backbone to from Δ4--Δ8,9Me-Cer \[III\] by Smt1. A Gcs1 transfers the glucose group to sphingoid backbone of ceramide structures at C1 position forming a β1-3-glycosidic bond. This results in formation of Δ4-GlcCer (IV), Δ4, Δ8-GlcCer (V) and Δ4--Δ8,9Me-GlcCer (VI) structures. The amide-linked fatty acyl in these structures is α-hydroxylated, a key feature. The respective SRM transitions used for the identification and quantification of these structures are shown as (Parent ion→Daughter ion). **(B)** Analysis of ceramide and glucosylcamides in sphingolipid pathway mutants of *C. neoformans*. The wild type strain CnWT shows a major pool of Δ4--Δ8,9Me-GlcCer (VI), where all other structures are present in negligible amounts. The CnΔ*smt1* strain does not produce Δ4--Δ8,9Me-GlcCer (VI) structure and accumulates Δ4, Δ8-Cer \[II\] which is converted to Δ4, Δ8-GlcCer \[IV\] by Gcs1. The CnΔ*gcs1* shows an accumulation of Δ4--Δ8,9Me-Cer (III). The pathway trends are represented by gray arrows in the wild type and mutant strains.](fmicb-07-00501-g005){#F5}

Although, HPLC-ESI-MS/MS presents as a powerful tool for qualitative and quantitative analysis of sphingolipids in fungi as well as other biological systems. It is important to note that ESI-MS/MS only gives limited information about the structure, especially if we are looking at an uncharacterized structure. For example, it is not possible to assign positions of double bonds, hydroxyl groups, and methylation based on limited fragmentation information. Extensive MS^n^ is necessary to provide some insights into the possible arrangement of the structure ([@B79]). However, such studies require more sophisticated instrumentation with high mass resolution, high sensitivity and sub part per-million accuracy are required. Confirmation of the exact structure is only possible using NMR spectroscopy of the purified lipid species ([@B76]). A routine sphingolipidome profiling of fungal lipids provides limited information regarding the rate at which these structures are synthesized or the activity of the enzymes that synthesize them. More detailed information of the metabolic flux of sphingolipid species may be achievable by using the labeling approaches like stable isotope (Ecker and Liebisch) or isotopomer analysis ([@B33]). Regardless of its limitations HPLC-ESI-MS/MS remains a method of choice for quantitative sphingolipidome profiling.
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CE

:   collision energy

CID

:   collision-induced dissociation

ESI

:   electrospray ionization

FAB

:   fast atom bombardment

FT-ICR

:   Fourier-transform ion cyclotron resonance

GC

:   gas chromatography

GC-EI-MS

:   gas chromatography-electron impact-mass spectrometry

Gcs1

:   glucosylceramide synthase

HILIC

:   hydrophilic-interaction liquid chromatography

HPLC

:   high-performance liquid chromatography

IPC

:   inositolphosphoryl ceramide

LCB

:   long-chain base

MALDI

:   matrix-assisted laser desorption/ionization

MIPC

:   mannosyl-inositol phosphorylceramide

MS/MS

:   tandem mass spectrometry

MS^n^

:   multiple-stage mass spectrometry

(M(IP)~2~C

:   mannosyldiinositolphosphoryl ceramide

MRM

:   multiple-reaction monitoring

NL

:   neutral loss

NMR

:   nuclear magnetic resonance spectroscopy

PREIS

:   precursor-ion scanning

QqTOF MS

:   hybrid quadrupole time-of--flight mass spectrometer

RF

:   radiofrequency

SRM

:   single-reaction monitoring

Smt1

:   sphingolipid C9 methyltransferase

Sld8

:   Δ8-desaturase

SPE

:   solid-phase extraction

TLC

:   thin-layer chromatography

TMS

:   trimethylsilyl

TOF

:   time-of-flight

UDP

:   uridine 5-diphosphate
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